TAIPEI (Taiwan News) — Taiwan's Lumosa Therapeutics Co. announced Thursday that it has received written guidance from the US ...
Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...
Earlier this week, Bayer announced positive topline results from its Phase III OCEANIC-STROKE trial, showing that asundexian ...
Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...
Bayer today announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian. The study met its primary efficacy ...
Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...
Verywell Health on MSN
Stroke vs. Heart Attack: How to Tell the Difference
Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.
Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.
Bayer’s asundexian meets primary efficacy and safety endpoints in landmark phase III OCEANIC-STROKE study in secondary stroke prevention: Berlin Tuesday, November 25, 2025, 11:0 ...
COVID-19 infection is associated with ischemic and hemorrhagic spinal stroke, with distinct clinical characteristics and underlying mechanisms.
Donald Glover, pictured in 2019, suffered a stroke while on tour in 2024. Credit - Gregg DeGuire—FilmMagic via Donald Glover ...
Left atrial appendage occlusion (LAAO) during cardiac surgery in patients with atrial fibrillation was associated with lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback